As you might expect from CES 2026, we're already starting to see all things AI. Gigabyte is just one company redoubling its ...

NVIDIA's consumer graphics presentation at CES 2026 was more interesting than many, although we'll spoil the surprise ...

FromSoftware has more or less abandoned one of its older IP, but its spirit lives on in two modern, first-person adventure ...

From Spindrift to CoreWeave to Databricks, here's what happened to the companies we thought would have a banner year.

The Maple Leafs took to the ice for practice on Monday after a day off on Sunday, and there was an interesting development involving Chris Tanev during the session. The Toronto Maple Leafs have ...

If software development were music, the past decade has been a jam session: developers riffing on code, improvising solutions … and occasionally hitting a sour note. But with AI increasingly stepping ...

So far, Netflix’s attempts at getting into the games business have been a bit of a mess. The streamer announced plans to work its way into the industry back in 2021, and later that year put out a thin ...

The Toronto Raptors have been linked to a lot of big names across the NBA and now the team is being named as a favourite to land Domantas Sabonis in a trade. Ben Rogers breaks down this latest ...

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...

Sim Story of Seasons: Grand Bazaar taught me that farming simulators don't have to follow the same routine to be just as fun as Stardew Valley this year Strategy Roguelite city builder Super Fantasy ...

Vepdegestrant is an investigational, orally bioavailable PROTAC estrogen receptor degrader. In the VERITAC-2 Phase 3 study, vepdegestrant demonstrated statistically significant and clinically ...